BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23824624)

  • 1. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.
    Koshiol J; Sklavos M; Wentzensen N; Kemp T; Schiffman M; Dunn ST; Wang SS; Walker JL; Safaeian M; Zuna RE; Hildesheim A; Pfeiffer RM; Pinto LA
    Int J Cancer; 2014 Jan; 134(2):411-25. PubMed ID: 23824624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
    Li X; Ding L; Song L; Gao W; Wang L; Wang J
    Int J Cancer; 2020 May; 146(9):2406-2412. PubMed ID: 31290154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia.
    Harris TG; Kulasingam SL; Kiviat NB; Mao C; Agoff SN; Feng Q; Koutsky LA
    Am J Epidemiol; 2004 May; 159(9):834-42. PubMed ID: 15105176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
    Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
    Int J Gynecol Pathol; 2008 Apr; 27(2):265-73. PubMed ID: 18317213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
    Jackson JA; Kapur U; Erşahin Ç
    Int J Surg Pathol; 2012 Apr; 20(2):146-53. PubMed ID: 22104735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
    Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study.
    Zhang HY; Tiggelaar SM; Sahasrabuddhe VV; Smith JS; Jiang CQ; Mei RB; Wang XG; Li ZA; Qiao YL
    Asian Pac J Cancer Prev; 2012; 13(1):91-6. PubMed ID: 22502720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection.
    Mimica M; Tomić S; Kardum G; Hofman ID; Kaliterna V; Pejković L
    Int J Gynecol Cancer; 2010 Jan; 20(1):116-9. PubMed ID: 20130511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience.
    Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
    Syrjänen K; Shabalova I; Sarian L; Naud P; Longatto-Filho A; Derchain S; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Serpa Hammes L; Podistov J; Costa S; Syrjänen S; ;
    Eur J Gynaecol Oncol; 2012; 33(1):5-14. PubMed ID: 22439398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1.
    Zhong P; Li J; Gu Y; Liu Y; Wang A; Sun Y; Lu L
    Int J Clin Exp Pathol; 2015; 8(3):2979-86. PubMed ID: 26045807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women.
    Kim J; Kim BK; Lee CH; Seo SS; Park SY; Roh JW
    Int J Gynecol Cancer; 2012 Nov; 22(9):1570-6. PubMed ID: 23051954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K
    Diagn Cytopathol; 2006 Nov; 34(11):739-48. PubMed ID: 17041957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
    Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
    Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras.
    Velema JP; Ferrera A; Figueroa M; Bulnes R; Toro LA; de Barahona O; Claros JM; Melchers WJ
    Int J Cancer; 2002 Feb; 97(4):536-41. PubMed ID: 11802219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.